The latest trading day saw Vertex Pharmaceuticals (VRTX) settling at $402.49, representing a -1.13% change from its previous close.

The artificial intelligence (AI) boom has taken the stock market by storm. The S&P 500 (SNPINDEX: ^GSPC) has advanced 55% in ...

Like its competitors, Google continues to experiment with low- and no-code tools that harness agentic AI for business ...

From beauty to fashion, consumer startups are seeking easy debt to expand inventory and facilitate marketing for quick ...

TreeFrog Therapeutics is making Cambridgeport Labs the site of its U.S. headquarters, leasing just under 13,500 square feet at the campus. The cell therapy biotech is moving to its own dedicated lab ...

Google's groundbreaking white paper reveals how AI agents leverage advanced reasoning, real-time data access and autonomous decision-making.

Obsidian Therapeutics, Inc., a clinical-stage biotechnology company pioneering engineered cell and gene therapies, today announced that Chief Executive Officer, Madan Jagasia, M.D., will present at ...

By the end of March, the regulator could clear a highly anticipated pain drug from Vertex and a heart drug that’s critical to Alnylam’s future.

Researchers have identified six new biomarkers that could detect kidney injury faster and with more sensitivity, advancing safer drug development and improving health outcomes for patients. The new ...

Drug-induced kidney injury, or nephrotoxicity, is a common complication in clinical medicine that happens when drugs damage ...

Today has seen a lot of movement in Russia's Kursk region, where Ukraine launched an offensive last year. We'll be back tomorrow with more updates on the war in Ukraine. But here is a look at the ...

The U.S. Congress formally certified Republican President-elect Donald Trump's November election victory over Democratic Vice President Kamala Harris, clearing the way for him to be sworn in on ...